title: Dramatic efficacy of brentuximab vedotin in two patients with epidermotropic cutaneous T-cell lymphomas after treatment failure despite variable CD30 expression.
authors.affiliation: Skin Cancer Unit, Nantes University Hospital, INSERM 892, 1 Place Alexis Ricordeau, 44093, Nantes Cedex, France.
authors.forename: C
authors.initials: C
authors.lastname: Saintes
authors.forename: M
authors.initials: M
authors.lastname: Saint-Jean
authors.forename: J J
authors.initials: JJ
authors.lastname: Renaut
authors.forename: B
authors.initials: B
authors.lastname: Dréno
authors.forename: G
authors.initials: G
authors.lastname: Quéreux
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000079963:Brentuximab Vedotin; D018450:Disease Progression; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use*; D017730:Ki-1 Antigen / Q000378:metabolism*; D016410:Lymphoma, T-Cell, Cutaneous / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012751:Sezary Syndrome / Q000188:drug therapy; D012878:Skin Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D018796:Immunoconjugates; D017730:Ki-1 Antigen; D000079963:Brentuximab Vedotin